Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-992-2 | CAS number: 101-96-2
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No studies on toxicokinetics are available. However, toxicokinetic information could be derived from acute oral and dermal toxicity studies. We can conclude that 44PD and/or its metabolites will be absorbed by the oral and dermal route. Although inconclusive data are available for the inhalation route, due to the systemic bioavailability via the oral route, it is likely that 44PD will also be absorbed by the inhalation route.
Key value for chemical safety assessment
Additional information
No studies on toxicokinetics are available. However, considering physicochemical properties and taking into account the results of 44PD in acute and repeated dose toxicity studies and skin irritation/corrosion tests, a characterization of 44PD toxicokinetics can be conducted.
44PD is a liquid with a calculated vapour pressure of 0.207 Pa at 25°C. Its molecular mass is 220.35 g/mol and it has a predicted log Kowof 3.5. The water solubility was estimated to be 33 mg/L.
Absorption resulting from oral exposure
In general, a log Kowvalue between -1 and 4 indicates that a molecule is favourable for absorption from the gastro-intestinal tract. Furthermore, a molecular weight <500 g/mol is believed to enhance the oral absorption. It can thus be concluded that 44PD will likely be absorbed from the gastro-intestinal tract upon oral intake.
Absorption resulting from dermal exposure
For compounds that are water soluble between 1 and 100 mg/L – which is the case for 44PD – dermal absorption is anticipated to be low to moderate. However, it has to be taken in account that the test substance is corrosive to the skin (Parent 1983). Damage to the skin surface may enhance penetration.
An abnormal coloration of the urine was observed in acute oral (rat) and dermal (rabbit) toxicity studies. This finding confirms a systemic bioavailability of 44PD or its metabolites.
We can conclude that 44PD and/or its metabolites will be absorbed by the oral and dermal route. Although inconclusive data are available for the inhalation route, due to the systemic bioavailability via the oral route, it is likely that 44PD will also be absorbed by the inhalation route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
